TipRanks
Advertisement
Advertisement

MX:BMY Stock Latest News

U.S. weighs allowing most pharma licensing deals with China, Reuters says
The FlyU.S. weighs allowing most pharma licensing deals with China, Reuters says
1d ago
AZN
BMY
Bristol Myers’ Sotyktu shows two-year efficacy in in psoriatic arthritis
PremiumThe Fly
Bristol Myers’ Sotyktu shows two-year efficacy in in psoriatic arthritis
2d ago
BMY
Bristol Myers price target raised to $82 from $75 at Piper Sandler
PremiumThe Fly
Bristol Myers price target raised to $82 from $75 at Piper Sandler
3d ago
BMY
BioMarin names Robert Plenge, M.D., Ph.D., to board of directors
PremiumThe Fly
BioMarin names Robert Plenge, M.D., Ph.D., to board of directors
5d ago
BMY
BMRN
Bristol Myers price target raised to $65 from $60 at HSBC
PremiumThe Fly
Bristol Myers price target raised to $65 from $60 at HSBC
9d ago
BMY
Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial
PremiumThe FlyBristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial
11d ago
BMY
Eikon Therapeutics appoints Ching-Pin Chang as chief scientific officer
Premium
The Fly
Eikon Therapeutics appoints Ching-Pin Chang as chief scientific officer
16d ago
BMY
EIKN
Novartis halts autoimmune CAR-T trials following three deaths, Reuters says
Premium
The Fly
Novartis halts autoimmune CAR-T trials following three deaths, Reuters says
18d ago
BMY
NVS
Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study
PremiumThe Fly
Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study
20d ago
BMY
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
PremiumThe Fly
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
24d ago
AA
MT
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
PremiumThe Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
25d ago
ABT
BMY
Bristol-Myers Squibb: Late-Stage Pipeline Catalysts Support Buy Rating and Unchanged $80 Price Target
PremiumRatings
Bristol-Myers Squibb: Late-Stage Pipeline Catalysts Support Buy Rating and Unchanged $80 Price Target
1M ago
BMY
Bristol-Myers Squibb: Sell Rating Reiterated as Competitive Pressures Mount; $40 Price Target Unchanged Signaling Further Downside
PremiumRatingsBristol-Myers Squibb: Sell Rating Reiterated as Competitive Pressures Mount; $40 Price Target Unchanged Signaling Further Downside
1M ago
BMY
Atrium Therapeutics earns $15M milestone payment from Bristol Myers
Premium
The Fly
Atrium Therapeutics earns $15M milestone payment from Bristol Myers
1M ago
BMY
RNA
Court revives suit against Bristol Myers over delayed drug, Reuters reports
Premium
The Fly
Court revives suit against Bristol Myers over delayed drug, Reuters reports
1M ago
BMY
UMBF
Bristol Myers’ first CELMoD myeloma therapy granted accelerated FDA approval
PremiumThe Fly
Bristol Myers’ first CELMoD myeloma therapy granted accelerated FDA approval
1M ago
BMY
Balanced Risk-Reward Keeps Bristol-Myers Squibb at Hold as Zenbexus CELMoD Opportunity Awaits Key 2026 Data
PremiumRatings
Balanced Risk-Reward Keeps Bristol-Myers Squibb at Hold as Zenbexus CELMoD Opportunity Awaits Key 2026 Data
1M ago
BMY
Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports
PremiumThe Fly
Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports
1M ago
AZN
BMY
Bristol Myers announces $2.3B campus in Houston, Texas
PremiumThe Fly
Bristol Myers announces $2.3B campus in Houston, Texas
1M ago
BMY
Midday Fly By: SpaceX slips, Disney reports earnings beat
PremiumThe FlyMidday Fly By: SpaceX slips, Disney reports earnings beat
2M ago
BX
MS
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
Premium
The Fly
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
2M ago
AZN
BBY
Bristol Myers upgraded to Buy from Hold at Argus
Premium
The Fly
Bristol Myers upgraded to Buy from Hold at Argus
2M ago
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >